Raymond James Financial Inc Ocuphire Pharma, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 14,980 shares of OCUP stock, worth $14,680. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,980Holding current value
$14,680% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OCUP
# of Institutions
46Shares Held
2.65MCall Options Held
14.1KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA992KShares$972,3560.0% of portfolio
-
Geode Capital Management, LLC Boston, MA272KShares$266,8350.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX166KShares$162,4350.0% of portfolio
-
Richmond Brothers, Inc. Jackson, MI156KShares$152,5070.13% of portfolio
-
Black Rock Inc. New York, NY107KShares$104,7960.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...